INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED FILES APPLICATION FOR "CAMLIPIXANT IN COMBINATION WITH CYP3A4 AND/OR CYP2C8 INDUCERS FOR USE IN THE TREATMENT OF CHRONIC COUGH"

GENEVA, Feb. 17 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/EP2025/072390) for "CAMLIPIXANT IN COMBINATION WITH CYP3A4 AND/OR CYP2C8 INDUCERS FOR USE IN THE TREATMENT OF CHRONIC COUGH" on Aug 04, 2025. With publication no. WO/2026/032924, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAURET, Nathalie (c/o GSKGSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY), GAHIR, Sarabjit Singh (c/o GSKGSK Medi...